- $3.06bn
- $3.49bn
- $1.71bn
- 85
- 33
- 82
- 73
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,327 | 3,071 | 1,426 | 1,563 | 1,707 |
Cost of Revenue | |||||
Gross Profit | 1,410 | 1,295 | 778 | 871 | 993 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,157 | 2,908 | 1,519 | 1,655 | 1,780 |
Operating Profit | 170 | 162 | -92.7 | -91.6 | -73 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 50.5 | 58 | -122 | -2.07 | -67.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 18.9 | 57.3 | -102 | -38.2 | -53.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -528 | 42.6 | 71.7 | -13.3 | -33.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -528 | 42.6 | 71.7 | -13.3 | -33.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.6 | 2.19 | -1.13 | 0.249 | 0.111 |